Bellver-Sanchis A

References (2)

Title : Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: Insights for Alzheimer's disease therapeutics - Grinan-Ferre_2023_CNS.Neurosci.Ther__
Author(s) : Grinan-Ferre C , Jarne-Ferrer J , Bellver-Sanchis A , Codony S , Puigoriol-Illamola D , Sanfeliu C , Oh Y , Lee S , Vazquez S , Pallas M
Ref : CNS Neurosci Ther , : , 2023
Abstract : Grinan-Ferre_2023_CNS.Neurosci.Ther__
ESTHER : Grinan-Ferre_2023_CNS.Neurosci.Ther__
PubMedSearch : Grinan-Ferre_2023_CNS.Neurosci.Ther__
PubMedID: 37905690

Title : A Combined Chronic Low-Dose Soluble Epoxide Hydrolase and Acetylcholinesterase Pharmacological Inhibition Promotes Memory Reinstatement in Alzheimer's Disease Mice Models - Jarne-Ferrer_2022_Pharmaceuticals.(Basel)_15_
Author(s) : Jarne-Ferrer J , Grinan-Ferre C , Bellver-Sanchis A , Vazquez S , Munoz-Torrero D , Pallas M
Ref : Pharmaceuticals (Basel) , 15 : , 2022
Abstract : Jarne-Ferrer_2022_Pharmaceuticals.(Basel)_15_
ESTHER : Jarne-Ferrer_2022_Pharmaceuticals.(Basel)_15_
PubMedSearch : Jarne-Ferrer_2022_Pharmaceuticals.(Basel)_15_
PubMedID: 35893732